CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The ExpandTILs project aims to enhance cancer immunotherapy by selectively amplifying tumor-reactive lymphocytes from patients. By using reprogrammed cancer cells, it seeks to improve the effectiveness of treatments against solid tumors.
Cancer affects 2.6 million people each year in the European Union, making it the second leading cause of death.
Immunotherapies have revolutionized the treatment of cancer, seeking to re-arm immune cells against tumors.
However, current immunotherapies are mostly inefficient in low immunogenic and solid tumors, which account for more than 80% of cancers in adults. A promising approach is to collect tumor infiltrating lymphocytes (TILs) from patient’s resected tumor tissue, and expand their funct…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
